MX2021014576A - Derivados heterociclicos condensados como agentes antivirales. - Google Patents

Derivados heterociclicos condensados como agentes antivirales.

Info

Publication number
MX2021014576A
MX2021014576A MX2021014576A MX2021014576A MX2021014576A MX 2021014576 A MX2021014576 A MX 2021014576A MX 2021014576 A MX2021014576 A MX 2021014576A MX 2021014576 A MX2021014576 A MX 2021014576A MX 2021014576 A MX2021014576 A MX 2021014576A
Authority
MX
Mexico
Prior art keywords
antiviral agents
fused heterocyclic
heterocyclic derivatives
compounds
preparing
Prior art date
Application number
MX2021014576A
Other languages
English (en)
Inventor
Scott D Kuduk
Chao- Yuan Wang
Jan Martin Berke
Lindsey Graham Deratt
Original Assignee
Janssen Sciences Ireland Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Unlimited Co filed Critical Janssen Sciences Ireland Unlimited Co
Publication of MX2021014576A publication Critical patent/MX2021014576A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La solicitud describe compuestos de derivados heterocíclicos condensados, composiciones farmacéuticas que comprenden estos compuestos, procesos químicos para preparar estos compuestos y su uso en el tratamiento de enfermedades asociadas con la infección por el VHB.
MX2021014576A 2019-05-28 2020-05-27 Derivados heterociclicos condensados como agentes antivirales. MX2021014576A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962853554P 2019-05-28 2019-05-28
EP19176954 2019-05-28
PCT/US2020/034654 WO2020243142A1 (en) 2019-05-28 2020-05-27 Fused heterocyclic derivatives as antiviral agents

Publications (1)

Publication Number Publication Date
MX2021014576A true MX2021014576A (es) 2022-01-11

Family

ID=71523196

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021014576A MX2021014576A (es) 2019-05-28 2020-05-27 Derivados heterociclicos condensados como agentes antivirales.

Country Status (10)

Country Link
US (1) US20220323455A1 (es)
EP (1) EP3976616A1 (es)
JP (1) JP2022535208A (es)
KR (1) KR20220012321A (es)
CN (1) CN113939512A (es)
AU (1) AU2020285719A1 (es)
BR (1) BR112021023216A2 (es)
CA (1) CA3138163A1 (es)
MX (1) MX2021014576A (es)
WO (1) WO2020243142A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024114709A1 (en) * 2022-12-01 2024-06-06 Janssen Sciences Ireland Unlimited Company A crystal form of a fused heterocycle derivative compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2993174A1 (en) * 2014-09-08 2016-03-09 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH Pyrazolopyridine derivatives and their use in therapy
US9518057B2 (en) * 2014-12-30 2016-12-13 Novira Therapeutics, Inc. Derivatives and methods of treating hepatitis B infections
JP6935433B2 (ja) 2016-06-29 2021-09-15 ノヴィラ・セラピューティクス・インコーポレイテッド ジアゼピノン誘導体及びｂ型肝炎感染症の治療におけるその使用
WO2018005881A1 (en) * 2016-06-29 2018-01-04 Novira Therapeutics, Inc. Oxadiazepinone derivatives and their use in the treatment of hepatitis b infections

Also Published As

Publication number Publication date
EP3976616A1 (en) 2022-04-06
US20220323455A1 (en) 2022-10-13
WO2020243142A1 (en) 2020-12-03
KR20220012321A (ko) 2022-02-03
CN113939512A (zh) 2022-01-14
JP2022535208A (ja) 2022-08-05
BR112021023216A2 (pt) 2022-01-04
CA3138163A1 (en) 2020-12-03
AU2020285719A1 (en) 2022-02-03

Similar Documents

Publication Publication Date Title
CR20210666A (es) Derivados heterocíclicos condensados
PH12019501034A1 (en) New anthelmintic quinoline-3-carboxamide derivatives
SA520420033B1 (ar) مركبات صيدلية
PH12020500257A1 (en) Quinoline derivatives for treating infections with helminths
MX2018012544A (es) Nuevos derivados de pirazolopirimidina.
PH12016501394A1 (en) Compounds for treating patients with ros1 mutant cancer cells
PH12019502851A1 (en) New azaquinoline derivatives
MX2017016781A (es) Derivados de sulfamoilarilamida ciclados y su uso como medicamentos para el tratamiento de la hepatitis b.
MY195002A (en) Benzoxazepin oxazolidinone compounds and methods of use
MX2018003186A (es) Derivados de 8-[6-[3-(amino)propoxi]-3-piridil]1-isopropilimidazo[ 4,5-c]quinolin-2-ona como moduladores selectivos de la cinasa de la ataxia telangiectasia mutada (atm) para el tratamiento del cancer.
GEP201606560B (en) Macrocyclic derivatives for the treatment of proliferative diseases
SG10201803331PA (en) Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
MX2019012803A (es) Nuevos derivados de pirazol biciclicos.
PH12020551891A1 (en) New quinoline derivatives
GEP20186938B (en) Indolizine derivatives as phoshoinositide 3-kinases inhibitors
IL286210A (en) Compressed ring pyrimidine history for use in the treatment of hbv infection or diseases caused by hbv
GEP20207128B (en) Aminothiazole derivatives useful as antiviral agents
WO2022116997A8 (en) Fused heterocyclic derivatives and their use in the treatment of hbv infection
JOP20190086A1 (ar) مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
MX2021014576A (es) Derivados heterociclicos condensados como agentes antivirales.
MX2021014581A (es) Derivados heterociclicos condensados.
PH12016501645A1 (en) Aminopyrazolone derivative
ECSP21092791A (es) Derivados heterocíclicos condensados
MX2022006489A (es) Derivado de anillo de piridina fusionado, metodo de preparacion y usos farmaceuticos del mismo.
EA202193275A1 (ru) Сочлененные гетероциклические производные